ProBiotix Health focus on groundbreaking probiotic menopause solutions at SupplySide Global, redefining women’s health beyond symptom relief

ProBiotix Health (‘ProBiotix’), a pioneer in advanced probiotic science, will be exhibiting its flagship probiotic strain, LP_LDL®, and new menopause support solutions, YourBiotix_MH and YourBiotix_PMH, at SupplySide Global. The event, being held on October 29-30 in Las Vegas, marks ProBiotix Health’s entry into the US women’s health market.

YourBiotix_MH and YourBiotix_PMH were formulated to reshape the conversation around menopause. Visitors to the ProBiotix Health stand at #7853 can explore the benefits of these formulations and discover how they not only address day-to-day symptom relief but long-term health risks for women in the menopause cohort.

Menopause – Solving the heart of the problem

Says Steen Andersen, chief operating officer at ProBiotix Health. “Menopause is a natural stage of life for most women, yet its impact extends far beyond hot flushes or sleep disturbances. The decline in estrogen during menopause profoundly impacts women’s health, increasing risks of high cholesterol, hypertension, arterial stiffness, and loss of bone density.”

Cardiovascular disease remains the leading cause of death among American women, with post-menopausal women 5X more likely to suffer a heart attack, while 77% of women aged 45+ have raised cholesterol.

“Most supplements on the market today stop at short-term relief. Although the US menopause supplement market is growing rapidly, it still lacks products that address these hidden long term health risks such as cardiovascular health and loss of bone density. Our new formulations aim to close this critical gap,” he says.

Unlike conventional supplements that focus mainly on vasomotor symptoms, YourBiotix_MH and YourBiotix_PMH harness the power of LP_LDL® (Lactobacillus plantarum), ProBiotix Health’s clinically validated probiotic strain. Formulated in combination with selected nutrients, including Isoflavones, Thiamine, Vitamin D, and Vitamin B6, these two products support positive menopausal outcomes.

Says Andersen, “These are the first probiotic-based solutions that offer a dual function: relieving and addressing the long-term cardiovascular, physiological, and bone health risks that accompany menopause, effectively enabling consumers to add life to years, not just years to life.”

The power of YourBiotix_MH in transforming women’s health is gaining acclaim throughout the nutraceutical industry. YourBiotix_MH was recently named as a finalist in the prestigious NutraIngredients Asia Women’s Health Innovation Award and shortlisted for a WholeFoods Women’s Health Award, further cementing its recognition as a breakthrough product.

Alongside YourBiotix_MH and _PMH, ProBiotix will also showcase LP_LDL® in finished formulations available for white label, highlighting its proven clinical benefits for cardiometabolic health.

LP_LDL represents the foundation of ProBiotix’s innovation pipeline strategy to extend probiotics beyond the gut to focus on cardiometabolic health and healthy ageing.

“We believe menopause is more than just a phase, and declining estrogen is more than discomfort – it’s a turning point in a woman’s cardiovascular health,” Andersen concluded. “With YourBiotix_MH and YourBiotix_PMH, we offer more than just relief, but a way to protect women’s health well into the future.”

Visit the ProBiotix team at booth #7853 at Supply Side Global on October 29-30 to discover LP_LDL® and the YourBiotix product range.

For press inquiries, product details, or to arrange a meeting with the team, (click here) to schedule a meeting.